Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502656
2.
High Asymptomatic Carriage With the Omicron Variant in South Africa.
Clin Infect Dis
; 75(1): e289-e292, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353885
3.
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Clin Infect Dis
; 72(1): 50-60, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900486
4.
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
PLoS Med
; 18(12): e1003868, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871308
5.
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
J Clin Microbiol
; 59(10): e0052721, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288726
6.
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
PLoS Med
; 17(5): e1003117, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442195
7.
Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response.
Infect Immun
; 82(12): 5214-22, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287926
8.
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.
EBioMedicine
; 100: 104987, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306894
9.
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region.
J Glob Health
; 13: 06020, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352144
10.
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Vaccine
; 41(16): 2696-2706, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935288
11.
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial.
Lancet HIV
; 10(10): e653-e662, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802566
12.
Accelerating clinical trial development in vaccinology: COVID-19 and beyond.
Curr Opin Immunol
; 76: 102206, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569415
13.
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.
Lancet HIV
; 9(11): e791-e800, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240834
14.
Broadly neutralizing monoclonal antibodies for HIV prevention.
J Int AIDS Soc
; 24 Suppl 7: e25829, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806308
15.
Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017.
Trials
; 22(1): 778, 2021 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742340
16.
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.
Vaccine
; 39(33): 4641-4650, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34229888
17.
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
J Acquir Immune Defic Syndr
; 87(1): 671-679, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587505
18.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr
; 87(1): 680-687, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587510
19.
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.
EClinicalMedicine
; 21: 100313, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382714
20.
igr Genes and Mycobacterium tuberculosis cholesterol metabolism.
J Bacteriol
; 191(16): 5232-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19542286